Stock Screener
| # | Symbol | Price | Change % | Market Cap▼ | Volume | Name | 1 Week % | 1 Month % | 3 Month % | 6 Month % | 1 Year % | Equity Type | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | VERA | 30.37 | -0.52 | 2.2B | 1.1M | Vera Therapeutics, Inc. Class A Common Stock | +8.50 | -2.00 | -5.39 | -13.72 | +6.71 | Common Stock | Biotechnology |
| 102 | BCRX | 8.45 | -0.82 | 2.2B | 3.5M | BioCryst Pharmaceuticals Inc | +10.46 | +4.06 | -5.90 | -8.05 | +15.44 | Common Stock | Biotechnology |
| 103 | IMNM | 18.21 | -0.44 | 2.1B | 1.3M | Immunome, Inc. | +1.22 | -12.83 | -19.99 | -19.89 | +13.32 | Common Stock | Biotechnology |
| 104 | ZYME | 28.98 | +0.94 | 2.1B | 2.9M | Zymeworks Inc. | +2.69 | +11.63 | +32.09 | +8.91 | +51.85 | Common Stock | Biotechnology |
| 105 | FTRE | 21.51 | -7.02 | 2.1B | 2.9M | Fortrea Holdings Inc. Common Stock | -8.97 | +10.88 | +12.21 | +76.60 | +105.64 | Common Stock | Biotechnology |
| 106 | ZLDPF | 33.08 | -2.36 | 2.1B | 391 | ZEALAND PHARMA A/S ORD | -2.36 | -13.18 | -30.36 | -30.17 | -58.21 | Common Stock | Biotechnology |
| 107 | PGEN | 5.55 | -16.42 | 2.0B | 8.1M | Precigen, Inc. Common Stock | -10.34 | -32.40 | -11.48 | +36.03 | +34.06 | Common Stock | Biotechnology |
| 108 | MESO | 15.16 | -3.25 | 2.0B | 376.0K | Mesoblast Limited | +23.45 | +5.87 | +6.99 | -3.69 | -9.00 | ADR | Biotechnology |
| 109 | SLS | 9.68 | -4.67 | 2.0B | 6.3M | SELLAS Life Sciences Group, Inc. Common Stock | -16.11 | -14.56 | -3.29 | +96.36 | +431.91 | Common Stock | Biotechnology |
| 110 | XERS | 10.71 | -0.37 | 2.0B | 1.6M | Xeris Biopharma Holdings, Inc. Common Stock | +5.00 | +15.78 | +32.55 | +70.54 | +10.41 | Common Stock | Biotechnology |
| 111 | SRPT | 18.43 | -4.16 | 1.9B | 1.3M | Sarepta Therapeutics,, Inc. Common Stock | +3.95 | +4.89 | +24.02 | -14.24 | -23.24 | Common Stock | Biotechnology |
| 112 | TRVI | 13.56 | -1.81 | 1.9B | 1.7M | Trevi Therapeutics, Inc. Common Stock | +7.53 | -4.37 | -25.70 | -2.23 | +16.30 | Common Stock | Biotechnology |
| 113 | ABSI | 11.16 | -7.77 | 1.9B | 4.6M | Absci Corporation Common Stock | +21.57 | +3.81 | +43.45 | +126.83 | +160.75 | Common Stock | Biotechnology |
| 114 | VIR | 11.22 | -4.51 | 1.9B | 1.3M | Vir Biotechnology, Inc. Common Stock | +6.15 | -0.62 | +29.56 | +12.20 | +88.25 | Common Stock | Biotechnology |
| 115 | AGIO | 30.55 | -17.94 | 1.8B | 3.1M | Agios Pharmaceuticals, Inc. | -17.43 | -5.94 | +1.76 | +8.49 | -29.35 | Common Stock | Biotechnology |
| 116 | QURE | 26.26 | +3.79 | 1.8B | 1.9M | uniQure N.V. | +17.07 | +12.37 | -39.81 | +37.27 | -61.20 | Common Stock | Biotechnology |
| 117 | NTLA | 12.45 | -5.90 | 1.7B | 4.1M | Intellia Therapeutics, Inc | +11.06 | +2.72 | +16.57 | -6.11 | -1.35 | Common Stock | Biotechnology |
| 118 | STOK | 27.02 | +2.53 | 1.7B | 1.9M | Stoke Therapeutics, Inc. Common Stock | +7.89 | +3.87 | -6.39 | -18.33 | -10.07 | Common Stock | Biotechnology |
| 119 | NUVB | 4.78 | +0.21 | 1.7B | 5.1M | Nuvation Bio Inc. | +4.59 | -14.03 | -24.49 | +6.46 | -8.43 | Common Stock | Biotechnology |
| 120 | REPL | 17.53 | +0.81 | 1.7B | 3.9M | Replimune Group, Inc. | +52.98 | +30.34 | +56.53 | +601.24 | +80.17 | Common Stock | Biotechnology |